Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Madrigal Pharmaceuticals, Inc. MDGL

Full chart Compare
Set alert

Price alert · MDGL

All alert types
395.62 USD -35.53 (-8.24%)

Nov 3, 2026, 3:56 PM EST

387.34 Day range 482.73
394.54 52-week range 602.83
YTD
-32.06%
1 year
-4.06%

Financial health

Altman Z-Score

16.26 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E -45.3×
FY 2016: -2.9×FY 2017: -36.1×FY 2018: -50.8×FY 2019: -19.3×FY 2020: -8.5×FY 2021: -5.8×FY 2022: -16.8×FY 2023: -11.6×FY 2024: -14.1×FY 2025: -45.3×
FY 2016 5y median -14.1× FY 2025
P/S 13.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 36.4×FY 2025: 13.6×
FY 2016 5y median 0.0× FY 2025
P/B 21.7×
FY 2016: 2.1×FY 2017: 6.2×FY 2018: 3.5×FY 2019: 3.4×FY 2020: 7.2×FY 2021: 7.1×FY 2022: 25.2×FY 2023: 10.7×FY 2024: 8.7×FY 2025: 21.7×
FY 2016 5y median 10.7× FY 2025
P/FCF -68.8×
FY 2016: -4.4×FY 2017: -50.1×FY 2018: -65.3×FY 2019: -33.6×FY 2020: -10.9×FY 2021: -7.6×FY 2022: -22.1×FY 2023: -13.3×FY 2024: -14.4×FY 2025: -68.8×
FY 2016 5y median -14.4× FY 2025
EV/EBITDA -50.0×
FY 2016: -1.5×FY 2017: -31.4×FY 2018: -49.2×FY 2019: -16.2×FY 2020: -8.2×FY 2021: -5.7×FY 2022: -16.1×FY 2023: -12.0×FY 2024: -14.6×FY 2025: -50.0×
FY 2016 5y median -14.6× FY 2025
EV/Sales 13.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 36.5×FY 2025: 13.8×
FY 2016 5y median 0.0× FY 2025
FCF Yield -1.5%
FY 2016: -22.7%FY 2017: -2.0%FY 2018: -1.5%FY 2019: -3.0%FY 2020: -9.2%FY 2021: -13.1%FY 2022: -4.5%FY 2023: -7.5%FY 2024: -7.0%FY 2025: -1.5%
FY 2016 5y median -7.0% FY 2025

Profitability

Gross Margin 94.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 96.5%FY 2025: 94.1%
FY 2016 5y median 0.0% FY 2025
Operating Margin -31.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -276.4%FY 2025: -31.3%
FY 2016 5y median 0.0% FY 2025
Net Margin -30.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -258.6%FY 2025: -30.1%
FY 2016 5y median 0.0% FY 2025
ROE -47.8%
FY 2016: -72.5%FY 2017: -17.1%FY 2018: -6.9%FY 2019: -20.2%FY 2020: -84.3%FY 2021: -123.3%FY 2022: -149.6%FY 2023: -92.2%FY 2024: -61.8%FY 2025: -47.8%
FY 2016 5y median -92.2% FY 2025
ROIC -31.6%
FY 2016: -68.6%FY 2017: -17.5%FY 2018: -8.5%FY 2019: -22.8%FY 2020: -85.7%FY 2021: -123.1%FY 2022: -118.7%FY 2023: -72.8%FY 2024: -57.0%FY 2025: -31.6%
FY 2016 5y median -72.8% FY 2025
ROA -22.9%
FY 2016: -64.0%FY 2017: -16.2%FY 2018: -6.8%FY 2019: -19.0%FY 2020: -70.5%FY 2021: -88.5%FY 2022: -81.5%FY 2023: -58.3%FY 2024: -44.7%FY 2025: -22.9%
FY 2016 5y median -58.3% FY 2025

Growth (YoY)

Revenue 432.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 432.1%
FY 2016 FY 2025
Operating Income 39.7%
FY 2016: -687.8%FY 2017: -27.6%FY 2018: -26.9%FY 2019: -134.8%FY 2020: -117.2%FY 2021: -17.5%FY 2022: -21.1%FY 2023: -29.6%FY 2024: -30.8%FY 2025: 39.7%
FY 2016 FY 2025
EPS (diluted) 41.3%
FY 2016: 98.7%FY 2017: 49.9%FY 2018: 12.6%FY 2019: -113.1%FY 2020: -176.7%FY 2021: -11.8%FY 2022: -17.8%FY 2023: -16.0%FY 2024: -9.6%FY 2025: 41.3%
FY 2016 FY 2025
Free Cash Flow 58.4%
FY 2016: 75.4%FY 2017: -27.4%FY 2018: -13.8%FY 2019: -63.7%FY 2020: -277.8%FY 2021: -16.6%FY 2022: -22.2%FY 2023: -44.7%FY 2024: -40.3%FY 2025: 58.4%
FY 2016 FY 2025

Financial Health

Current Ratio 4.0×
FY 2016: 8.6×FY 2017: 19.1×FY 2018: 57.5×FY 2019: 17.5×FY 2020: 6.1×FY 2021: 3.5×FY 2022: 3.1×FY 2023: 5.4×FY 2024: 6.1×FY 2025: 4.0×
FY 2016 5y median 4.0× FY 2025
Quick Ratio 3.8×
FY 2016: 8.6×FY 2017: 19.1×FY 2018: 57.5×FY 2019: 17.5×FY 2020: 6.1×FY 2021: 3.5×FY 2022: 3.1×FY 2023: 5.4×FY 2024: 5.9×FY 2025: 3.8×
FY 2016 5y median 3.8× FY 2025
Debt / Equity 0.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.6×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA -0.6×
FY 2016: 1.6×FY 2017: 4.8×FY 2018: 1.8×FY 2019: 0.5×FY 2020: 0.3×FY 2021: 0.1×FY 2022: 1.0×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.6×
FY 2016 5y median -0.0× FY 2025
Interest Coverage -13.5×
FY 2016: -21.5×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -74.1×FY 2023: -29.9×FY 2024: -33.9×FY 2025: -13.5×
FY 2016 5y median -29.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31